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Despite limited bioavailability and rapid degradation, dietary anthocyanins are antioxidants with cardiovascular beneﬁts. This
study tested the hypothesis that the antioxidant protection conferred by the anthocyanin, delphinidin, is mediated by
modulation of endogenous antioxidant defences, driven by its degradation product, gallic acid. Delphinidin was found to
degrade rapidly (t1/2~ 30min), generating gallic acid as a major degradation product. Both delphinidin and gallic acid
generated oxygen-centred radicals at high (100 μM) concentrations in vitro. In a cultured human umbilical vein endothelial cell
model of oxidative stress, the antioxidant protective eﬀects of both delphinidin and gallic acid displayed a hormesic proﬁle;
100 μM concentrations of both were cytotoxic, but relatively low concentrations (100 nM–1 μM) protected the cells and were
associated with increased intracellular glutathione. We conclude that delphinidin is intrinsically unstable and unlikely to confer
any direct antioxidant activity in vivo yet it oﬀered antioxidant protection to cells at low concentrations. This paradox might be
explained by the ability of the degradation product, gallic acid, to confer beneﬁt. The ﬁndings are important in understanding
the mode of protection conferred by anthocyanins and reinforce the necessity to conduct in vitro experiments at biologically
relevant concentrations.
1. Introduction
Anthocyanins are polyphenolic phytochemicals that, although
not essential for survival, are among the factors that contribute
to the health beneﬁts of a fruit-rich diet. From a cardiovascular
perspective, polyphenols have been associated with a reduc-
tion in mortality associated with heart disease, a lower
incidence of myocardial infarction [1, 2], reduced blood
pressure [3–5], and protection against atherosclerosis [6–10].
The mechanisms through which phenolics exert their cardio-
protective actions are not yet fully understood, but protection
against oxidative damage and modulation of vascular function
is strongly implicated [5, 9, 11–17].
Reactive oxygen species (ROS) play an important role in
cardiovascular disease [11, 18, 19]. Oxygen-centred free
radicals have a cytotoxic and proinﬂammatory eﬀect on
endothelial cells that line blood vessels [20, 21]; superoxide
(O2
∙−) readily reacts with the cardioprotective agent, NO,
generating highly cytotoxic peroxynitrite (ONOO−; [22]).
Furthermore, ROS-mediated oxidation of critical lipids, and
low-density lipoprotein (LDL) in particular, is a key event
in the pathogenesis of atherosclerosis [23]. ROS are also
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prothrombotic via promotion of platelet activation [18].
Taken together, these characteristics of ROS impact on all
of the critical stages of atherothrombotic disease, from endo-
thelial dysfunction and inhibition of protective NO to oxida-
tive modiﬁcation of LDL and promotion of inﬂammation
and thrombosis [19]. Elimination of ROS by antioxidants is
an attractive therapeutic option.
Anthocyanins are abundant in a wide range of berries
(e.g., blackberries, blackcurrants, raspberries, red grapes,
cranberries, and elderberries) and are considered to be strong
antioxidants on account of their polyphenolic structure
[7, 24–30]. At least some of the cardiovascular beneﬁts
of red wine are mediated by anthocyanins, particularly
delphinidin [12, 17, 31, 32]. A link has long been forged
between the antioxidant potential of anthocyanins and
their protective eﬀects in cardiovascular health, but they
are characterised by low bioavailability (~1 μM) and the
concentrations required to induce direct antioxidant activity
are unachievable in vivo [12, 14, 33–38]. This aspect is often
cited as a major ﬂaw in the argument that polyphenols mod-
ulate the beneﬁts attributed to red wine.
Berry-derived anthocyanins are typically found in the
more stable glycosylated form, but after consumption, they
are subjected to digestive processes that deprive them of the
sugar moiety, releasing the less stable aglycone [34, 36].
Under physiological conditions, sugar-free anthocyanins
can degrade further into smaller phenolic compounds (e.g.,
phenolic acids and aldehydes [39–42]). The form in which
they are absorbed and exist in the bloodstream remains
unclear, but it is likely that the degradation products (simple
phenolic acids and/or aldehydes) might predominate over
the parent compounds [11, 40]. This detail is important
because phenolic compounds have been shown to have para-
doxical prooxidant properties [33, 43–46], a concept that
would throw into question how ingestion of the parent poly-
phenols could confer direct antioxidant activity in vivo.
It is becoming increasingly recognised that phenolic
compounds, including anthocyanins, can interact with vari-
ous molecular targets and aﬀect multiple signalling pathways,
providing an alternative putative mechanism to confer anti-
oxidant activity which is consistent with the low concentra-
tions found in vivo [13, 47–55]. This study set out to test
the hypothesis that the protective eﬀects of biologically
relevant concentrations of the anthocyanin, delphinidin, in
cultured endothelial cells are mediated by upregulation of
endogenous antioxidant defences by the primary metabolite,
gallic acid.
2. Materials and Methods
2.1. Materials. Chemicals, reagents, and consumables were
purchased from the following manufacturers: delphinidin
chloride (Extrasynthese, Genay, France); DMSO, ascorbic
acid, formic acid, gallic acid, gelatin solution (type B, 2% in
H2O), endothelial cell growth supplement, sodium pyruvate,
HEPES solution, 0.5% trypsin/EDTA (1X), iron(lll) chloride
(FeCl3), 2,4,6-tri(2-pyridyl)-s-triazine (TPTZ), and ferrous
sulfate heptahydrate (FeSO4·7H2O) (Sigma-Aldrich, Poole,
Dorset, UK); basal medium M199 (+Earle’s, +L-glutamine,
and +phenol red) and basal medium M199 (+Earle’s, +L-
glutamine, −phenol red, and +bicarbonate) (Invitrogen,
Paisley, UK); pyrogallol, methanol, acetonitrile, ethanol,
acetone, Coomassie (Bradford) reagent kit, sodium acetate,
and hydrochloric acid (Thermo Fisher Scientiﬁc Ltd.,
Loughborough, UK); Tempone-H hydrochloride and ROS-
ID® Total ROS/Superoxide detection kit (ENZO Life
Sciences Ltd., Exeter, UK); PBS (without Ca and Mg), foetal
bovine serum, penicilin/streptomycin (100X), and bovine
serum albumin (PAA Laboratories GmbH, Pasching,
Austria); HUVECs (Cell Applications Inc., San Diego, CA,
USA); heparin sodium (Wockhardt Ltd., Wrexham, UK);
GSH, catalase, and SOD assay (Cayman Chemical Company,
Ann Arbor, MI, USA); and ﬁlter vials (Thomson single
StEP standard ﬁlter vials) (Thomson Instrument Company,
Oceanside, CA, USA).
2.2. Determination of Delphinidin Degradation Proﬁle and
Products in Tissue Culture Medium
2.2.1. Spectrophotometry. It was important to understand the
degradation pattern of delphinidin under our experimental
conditions at the outset in order to inform the subsequent
functional experiments. Delphinidin (200 μM; the lowest
concentration easily measurable by spectrophotometry)
decomposition was tested in phenol red-free tissue culture
medium (pH 7.4, 37°C) containing 0.2% DMSO, alone or in
the presence of the superoxide generator, pyrogallol
(100 μM), or the antioxidant and reducing agent, ascorbic
acid (5mM). Delphinidin is subject to a bathochromic
shift—a change in absorption peak to a higher value, depen-
dent on the environmental conditions [56]. Absorbance
(λ=585nm) was therefore measured (every 10 minutes
for the ﬁrst hour, then every hour for 7 consecutive
hours, and ﬁnally at 24 h) using a plate reader (Varioskan
Flash with operating software SkanIt version 2.4; Thermo
Fisher Scientiﬁc Ltd., Loughborough, UK; pre-heated to
37°C). Each experiment was performed on three separate
occasions (n = 3).
2.2.2. LC-MS/MS. Delphinidin (100 μM) was incubated in
tissue culture medium for 30 minutes (humidiﬁed incubator
(Heracell 150 CO2, Thermo Fisher Scientiﬁc, Loughborough,
UK), 37°C, pH 7.4, 5% CO2, in the dark). Control samples
were treated with vehicle only (0.2% (v/v) DMSO). All sam-
ples were collected after 30min and extracted as follows: pro-
teins were precipitated from the collected tissue culture
medium (1ml) by addition of an equal volume of extraction
buﬀer (ice cold 100% methanol containing 0.2% formic acid
(v/v)). Samples were kept on ice for 1 h, prior to centrifuga-
tion (5min, room temperature, 10,000g). The supernatant
was removed and kept on ice. The pellet was resuspended
in ice cold 50% methanol containing 0.1% formic acid (v/v)
and centrifuged as before. The extraction procedure was
repeated three times in order to extract as many phenolic
compounds as possible. All supernatants were combined
and centrifuged once more (3min, 5000g). The collected
supernatants were kept at −80°C prior to analysis using liquid
chromatography-mass spectrometry (LC-MS/MS).
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The volume of extracts was reduced to dryness by evapo-
ration in a vacuum concentrator (SpeedVac, Thermo Fisher
Scientiﬁc Ltd., Loughborough, UK; no heat) prior to resus-
pension in 100 μl of 50% methanol containing 0.1% formic
acid (v/v). Samples were transferred into ﬁlter vials (polyte-
traﬂuoroethylene, 0.45 μm membranes) prior to analysis by
LC-MS/MS (LTQ Orbitrap XL LC-MS ﬁtted with an Acella
600 Pump, Acella photodiode array detector (PDA) detector,
and Acella autosampler) in both positive and negative ion
modes. The PDA scanned the wavelength range λ=200–
600nm. There were two scan events: Fourier transform mass
spectrometer full scan (80–2000m/z) analysis was followed
by data-dependent MS/MS of the most intense ions using a
normalised collision energy of 45%. The capillary tempera-
ture was set at 300°C, with sheath gas at 40 psi and auxiliary
gas at 5 psi. Samples (8 μl) were eluted over a gradient of
0.1% formic acid in ultrapure water (A), 0.1% formic acid
in 50% aqueous acetonitrile (B), and 0.1% formic acid in
95% aqueous acetonitrile (C) on a C18 column
(50× 2.1mm, 1.9 Hypersil GOLD) at a ﬂow rate of
700 μl/min. Exact mass data were analysed using the res-
ident Xcalibur Qual Browser software. The experiment
was performed on 3 separate occasions (n = 3).
2.3. Antioxidant Activity: FRAP Assay. Antioxidant potential
was measured using the ferric reducing ability of plasma
(FRAP) assay according to the procedure described by Benzie
and Strain [57], with minor modiﬁcations. Brieﬂy, 100 μl of
1% (v/v) test sample was mixed with 900 μl of freshly
prepared FRAP reagent, consisting of 20mM ferric chloride
(in water), 10mM TPTZ (in 40mM HCl), and 300mM
sodium acetate buﬀer (pH 3.6) in a volume ratio of 1 : 1 : 10,
respectively. Absorbance after a 4min incubation was
measured at λ=593nm by spectrophotometry (Ultrospec
2100 pro; GE Healthcare Life Sciences, Little Chalfont, UK;
[57]). Ferrous sulphate (FeSO4, in water) was used as a
reference standard.
2.4. Prooxidant Measurements: EPR Spectrometry. Electron
paramagnetic resonance (EPR) is a spectrometric technique
that facilitates detection of chemical species that possesses
one ormore unpaired electrons, such as free radicals and tran-
sition metal ions. EPR spectrometry detects free radicals
unambiguously [58]. It measures the absorption of energy by
unpaired electron(s) of the free radical species in the presence
of magnetic ﬁeld. Free radicals, however, are highly reactive
chemical species andare very short-lived as a result. Therefore,
we used the EPR spin-trapping technique in order to deter-
mine the radical production by selected phenolic compounds.
EPR spin trapping is amethod that is based on the reaction of a
free radical with an EPR-silent spin trap. The product of this
reaction, the EPR-active adduct, ismore stable than the parent
radical and exhibits characteristic multilined EPR spectrum
(Figure 1(b)) [59].TheEPRspectrumof a single unpaired elec-
tron consists only of one line. Multilined EPR spectra are
generated as a consequence of the interaction between the
magnetic spin of the unpaired electron and the nuclear
spin of a neighbouring nucleus within the spin trap;
this is called hyperﬁne splitting (Figure 1(b)) [59, 60].
Tempone-H (1-hydroxy-2,2,6,6-tetramethyl-4-oxo-piperi-
dine hydrochloride) is frequently used in detection and
quantifying of oxygen-centred radicals such as superoxide
and hydroxyl radicals [61–63] and was used here in order
to assess the prooxidant potential of delphinidin and gallic
acid. The technique cannot discriminate between diﬀerent
oxygen-centred radicals but excludes nonradical species
and, through choice of spin-trap, can select for a speciﬁc
class of radical species (e.g., Tempone-H for oxygen-
centred radicals).
Phenolic compounds (delphinidin and gallic acid), at
concentrations that encompassed the physiologically rele-
vant range (10 nM–100 μM), were prepared in tissue culture
medium prior to addition of Tempone-H (10mM stock, dis-
solved in ultrapure water) to generate a ﬁnal concentration of
2mM. 50 μl volumes of samples were drawn into a glass cap-
illary tubes and inserted into an EPR spectrometer (Minis-
cope MS200 spectrometer, Magnettech, Germany, with the
following parameter settings: magnetic ﬁeld (B0) 3343.48G,
sweep 49.10G, sweep time 60 sec, smooth 1 sec, 4096 steps,
modulation 2000mG, microwave attenuation 10 dB, and
gain 2× 101). EPR spectra were acquired as ﬁrst derivatives.
Formation of 4-oxo-tempo adduct generates a character-
istic 3-line EPR spectrum centred at 3340 Gauss. Peak inten-
sity is proportional to the concentration of adduct formed
(Figure 1(b)). Pro-/antioxidant activity of tested compounds
was determined by measuring 4-oxo-tempo signal intensity
generated after a 30min incubation period (37°C in the dark)
in tissue culture medium containing delphinidin or gallic
acid. Tissue culture medium alone acted as a control. Proox-
idant activity of phenolic compounds corresponded to an
increase in spin adduct formation compared to vehicle,
whereas antioxidant activity resulted in reduced radical for-
mation compared to vehicle.
2.5. Human Umbilical Vein Endothelial Cell (HUVEC)
Culture. HUVECs were propagated from pooled primary
cultures of human umbilical cords, prescreened for VEGF-
R2, Etk/Bmx, eNOS, Tie2, and Axl (Cell Applications Inc.,
San Diego, CA, USA), and supplied by the European Collec-
tion of Cell Cultures. HUVECs were subcultured according
to the supplier’s protocol, with minor modiﬁcations. Brieﬂy,
the cells were grown in ﬂasks or on plates coated with gelatin
(diluted 1 : 1 (v/v) with PBS), in growth medium, prepared
according to the recipe described previously [64]. Basal
medium M199 (+Earle’s and +L-glutamine) was supple-
mented with 20% (v/v) foetal bovine serum, 100 μg/ml pen-
icillin/streptomycin, 20 μg/ml endothelial cell growth
supplement, 10 μg/ml heparin, 20mM HEPES, and 2mM
sodium pyruvate as an additional source of energy. HUVECs
were grown in a humidiﬁed incubator (Heracell 150 CO2,
Thermo Fisher Scientiﬁc, Loughborough, UK) at 37°C, 5%
CO2, and passaged every 3-4 days, until they reached 80%
conﬂuence, determined by visual assessment. During subcul-
turing, the cells were lifted using Trypsin/EDTA (0.05%/
0.02%) and gentle agitation. Cells were counted using a hae-
mocytometer and plated in 75 cm2 ﬂasks (7.5× 105 cells) for
further culture, or onto 6-well and 24-well plates (1× 105
and 2× 104 cells per well, resp.) for experiments. All studies
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were performed on 80% conﬂuent HUVEC cultures at the
sixth passage.
2.6. Cell Treatment—Phenolic and Oxidant Preparation.
Samples containing phenolic compounds (1 nM–100 μM)
wereprepared inwarmed (37°C)phenol red-free tissue culture
medium. Additionally, some of the delphinidin samples were
incubated in culture medium for 1 h prior to application to
cells in order to initiate delphinidin degradation and to obtain
amixture consisting of native delphinidin and its degradation
products. The obtained mixture is referred to as “aged del-
phinidin” for use in subsequent cell culture experiments.
Three cell culture models of oxidative stress were used in
the study: pyrogallol (superoxide radical generator, O2
∙−;
[65]), hydrogen peroxide (H2O2; [66]), and pyocyanin (intra-
cellular O2
∙− generator, via induction of mitochondrial
dysfunction; [67]). All oxidants were prepared in warmed
(37°C) phenol red-free tissue culture medium deprived of
sodium pyruvate, which is known hydrogen peroxide scaven-
ger, therefore not appropriate for oxidative stress model
studies [68].
Due to the fact that HUVECs were pooled from diﬀerent
donors, their susceptibility to oxidants varied from batch to
batch. The concentrations of oxidising agents were therefore
optimised prior to test experiments for each batch of cells, in
order to select an appropriate concentration of each oxidant
that caused a submaximal, but easily detectable loss of cell
viability after 24 h (20–70%). Concentrations of pyrogallol
used in test experiments varied from 100 μM to 180 μM.
2.7. Assessment of Cell Viability: Trypan Blue Exclusion and
MTT Assay. The Trypan blue exclusion assay was used in
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Figure 1: (a) Ferric reducing ability of plasma (FRAP) of delphinidin (Del) and gallic acid (GA) in culture medium (n = 3 for each phenolic;
∗∗∗P < 0 001, 2-factor ANOVA with Bonferroni posttest). (b) Electron paramagnetic resonance spectra of delphinidin samples (1 nM and
100 μM) in tissue culture medium containing 2mM Tempone-H at time 0 and 30min. Addition of a superoxide radical (produced by
delphinidin) to the EPR-silent spin trap (Tempone-H) forms a persistent adduct (4-oxo-tempo) which is EPR active and displays
multiline spectrum characteristic of an unpaired electron in the vicinity of a nucleus. (c) Rate of oxygen-centred free radical production by
Del and GA in tissue culture medium. Prooxidant activity: tested compound generated more radicals than tissue culture medium alone.
Antioxidant activity: tested compound reduced the amount of free radicals produced by medium alone (n = 5 for each phenolic; ∗P < 0 05,
2-factor ANOVA).
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some studies for routine cell counting but was also used to
determine the level of cytotoxicity of the test phenolic agents.
Following trypsinization, Trypan blue (0.1% v/v) was added
to the cell culture well (1 : 1, 5min) prior to cell counting
(stained and unstained) using a haemocytometer. The
amount of live (Trypan blue negative) and dead (Trypan blue
positive) cells was expressed as the number of stained or
unstained per ml.
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) reduction assay is a metabolic activity assay
that is frequently used to measure cell viability. Viable cells
with active metabolism reduce yellow MTT to stable, purple,
coloured formazan crystals, which can be dissolved. Dead cells,
on the other hand, lose the ability to convert MTT into forma-
zan product. The purple solution is measured spectrophoto-
metrically, and its formation is a suitable indicator of cell
viability. The mechanism through which the reduction of
MTT occurs is not fully understood but most likely involves
reaction with mitochondrial NADH and/or other intercellular
reducing agents [69–71].
The MTT assay was conducted following the manufac-
turer’s protocol, with minor modiﬁcations. Brieﬂy, HUVECs
were seeded at 2× 104 cells per well in 24-well plates and
treated as required. 24 hours after a treatment, MTT (50 μl;
ﬁnal volume of 0.25mg/ml) was added to each well. The cells
were incubated at 37°C for 4 h to ensure complete reduction
of MTT to formazan crystals. The culture medium was care-
fully removed prior to addition ofMTT solubilisation solution
and gentle agitation for 10min. Absorption (λ=570 nm) was
measured using a plate reader (Varioskan Flash, Thermo
FisherScientiﬁcLtd., Loughborough,UK).Backgroundabsor-
bance at λ=630nm was also measured for subsequent
subtraction from λ=570nm readings. Experiments were
repeated on 6–11 separate occasions, each in triplicate.
2.8. Superoxide Assay. Superoxide was measured using a ﬂu-
orometric technique (ROS-ID Total ROS/Superoxide detec-
tion kit; Enzo Life Sciences Ltd.) that allows real-time
measurement of (a) superoxide and (b) nonspeciﬁc ROS
generation in cells. The kit contains a cell-permeable dye
(orange probe) that reacts speciﬁcally with O2
∙− [72, 73], gen-
erating an orange ﬂuorescent product that can be detected by
a ﬂuorescence plate reader equipped with standard orange
ﬁlter sets (λ=550/610 nm).
For this experiment, HUVECs were seeded at 2 × 104 cells
per well in 24-well plates. The cells were cotreated with pyro-
gallol (140 μM) with or without delphinidin or gallic acid at
concentrations of 1 nM, 1 μM, and 100 μM. Superoxide
generation was measured at 4, 8, 12, and 24 h after treatment,
following the manufacturer’s protocol. Brieﬂy, after the
required amount of time, tissue culture mediumwas removed
from the wells and discarded. HUVECs were washed imme-
diately with 500 μl/well of the supplied wash buﬀer. These
steps reduce the likelihood of direct interference of the exog-
enous agents on the assay. Following wash buﬀer removal,
400 μl/well of superoxide detection mix (2 μl of superoxide
detection reagent/10ml of wash buﬀer) was added prior to
incubation of plates in a humidiﬁed incubator (37°C, 5%
CO2) and reading on a plate reader (λEx = 550 nm and
λEm=610nm) without removing the detection mix. The
experiment was performed on 6–8 separate occasions, each
in triplicate. Data from the four time points was integrated
into an area under the curve for each experiment.
2.9. Total Glutathione Concentration, Catalase, and SOD
Activity Assays. HUVECs were cultured in 6 well plates
according to the method described above. The cells were
cotreated with the superoxide radical generator, pyrogallol
(180 μM) and delphinidin or gallic acid, at concentrations
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Figure 2: (a) Percent of delphinidin (Delph; 200 μM at T0) remaining in tissue culture medium (pH 7.4, 37
°C), when alone and in the
presence of the oxidising agent (pyrogallol, 100 μM) or the reducing agent/antioxidant, ascorbic acid (5mM). (b) Semilogarithmic
representation of percent of Delph remaining in solution; dotted lines indicate the respective half-lives in the presence and absence of
ascorbic acid. The results are expressed as mean± SEM (a) and mean only (b).
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that caused the most prominent protective eﬀect against
chemically induced oxidative stress (100 nM and 1 μM).
GSH, catalase, and SOD assays were performed accord-
ing to the manufacturer’s protocol (Cayman Chemical
Company). Total intracellular GSH concentration, SOD, and
catalase activities were normalised to the amount of the pro-
tein present in cultured cells, determined using the Coomassie
assay following the manufacturer’s protocol (Thermo Fisher
Scientiﬁc Ltd., Loughborough, UK). The experiment was
performed on 6 separate occasions, each in duplicate.
2.10. Statistical Analysis. The results are expressed as mean
± SE. Statistical analysis (one-factor ANOVA with Dunnett’s
posttest, 2-factor ANOVA where applicable) was performed
using GraphPad Prism software version 5.01 (GraphPad
Software, San Diego, USA). P values of less than 0.05 were
considered to be signiﬁcant.
3. Results
3.1. Determination of Delphinidin Degradation Pattern in
Tissue Culture Medium (37°C, pH 7.4) Spectrophotometry.
Delphinidin (200 μM) was unstable in tissue culture medium
(37°C, pH 7.4). The degradation process started immediately
and was most rapid in the ﬁrst hour (Figure 2(a)); a semilog-
arithmic plot indicated a linear relationship between log
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Figure 3: LC-MS chromatograms of sample containing (a) standards, (b) culture medium alone, and (c) delphinidin (100 μM; pH 7.4,
temperature 37°C) after 30 minute incubation.
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concentration and time, suggesting decay by ﬁrst order kinet-
ics (Figure 2(b)). Ascorbic acid (5mM) slowed the degrada-
tion process, but the oxidant, pyrogallol, did not
signiﬁcantly aﬀect the stability of delphinidin. The half-life
was very short, (~30min in the absence of ascorbic acid;
Figure 2(a)); ~80% of delphinidin was lost in the ﬁrst hour.
Ascorbic acid increased the half-life to >1.5 h (Figure 2(a)).
3.2. Identiﬁcation of Delphinidin Degradation Products in
Tissue Culture Medium. Two delphinidin degradation prod-
ucts of relatively low molecular weight were identiﬁed in
phenol red-free tissue culture medium (pH 7.4, temperature
37°C) after 30min incubation, using LC-MS/MS: gallic acid
(GA; peak 1) and phloroglucinol aldehyde (peak 3)
(Figure 3). The parent compound (peak 4) was also still pres-
ent at this time point. An unknown compound (peak 2) that
was not present in the control samples was also detected.
Based on the characteristics gathered from the LCMS/MS
analysis (Table 1), the compound was putatively identiﬁed
as chalcone on account of absorption maxima at λ~ 220
and 320nm [74]. Moreover, the peak contained a main ion
at 321 (m/z) [M+H], which fragmented into two smaller
ions at 303.03 and 152.97 (m/z), corresponding to delphini-
din and aldehyde, respectively (Table 1).
3.3. Antioxidant Potential. The FRAP assay was only able to
detect antioxidant activity in delphinidin and GA concentra-
tions of ≥10 μM (Figure 1(a)). There was a small (~5%) but
signiﬁcant higher antioxidant potential for delphinidin com-
pared to gallic acid, as measured by FRAP (2-way ANOVA
with Bonferroni posttest P < 0 001 for 10 and 100 μM).
3.4. Measurement of Pro-/Antioxidant Properties (EPR
Spectroscopy). Both delphinidin and gallic acid exhibited
oxygen-centred radical generating activity when present at
10 μM and 100 μM. Gallic acid also showed modest free
radical scavenging properties at ≤1 μM concentrations
(Figure 1(c)). The radical-generating eﬀect was signiﬁcantly
higher for delphinidin than gallic acid across the concentra-
tion range (Figure 1(c); 2-factor ANOVA, P < 0 05).
3.5. Eﬀects of Delphinidin and Gallic Acid on Viability of
HUVECs Determined by Trypan Blue Exclusion. Delphinidin
and gallic acid did not have a signiﬁcant impact on cell integ-
rity at concentrations≤ 10 μM, as measured by Trypan blue
exclusion assays. However, both agents at concentrations of
100 μM caused a signiﬁcant (~30 and 50%, resp.) reduction
in Trypan blue-negative cells (Figure 4). Moreover, 100 μM
gallic acid caused a modest increase in Trypan blue-positive
cells (~5%).
3.6. Eﬀects of Delphinidin and GA on Viability of Pyrogallol-
Induced Cell Death in HUVECs. Pyrogallol induced a loss of
cell viability (~30–70%; MTT assay) that was at least partially
protected against by delphinidin, aged delphinidin, and GA
at concentrations of ≤10 μM (Figure 5). The eﬀect was the
clearest for delphinidin (Figure 5(a)) and aged delphinidin
(Figure 5(b)), where cell viability was entirely protected by
concentrations of 10nM–10 μM (peaking at ~1 μM). 100 μM
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Figure 4: Number of Trypan blue-negative and Trypan blue-positive HUVECs after treatment (24 h) with increasing concentrations of
(a) delphinidin (Del) and (b) gallic acid (GA), determined by Trypan blue exclusion. Values are shown as mean± SEM (n = 5);
∗P < 0 05 and ∗∗∗P < 0 001 indicate the diﬀerence between Trypan blue-negative cells and the vehicle-treated control (one-way
ANOVA with Dunnett’s posttest).
Table 1: Chromatographic and mass spectrometric properties of
delphinidin and its degradation products.
Peak
number
RT
(min)
Abs max
(nm)
[M+H] [M−H] Putative
identiﬁcation
1 0.43 220, 270 N/A 169.01 Gallic acid
2 2.02 224, 320 321.06 319.04 Chalcone
3 2.13 227, 291 155.03 153.02 Aldehyde
4 2.30 280, 529 303.05 N/A Delphinidin
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delphinidin and aged delphinidin induced additional cyto-
toxic eﬀects that were greater than those seen with pyrogallol
alone; the additional eﬀect was similar in amplitude to that
seen with delphinidin in the absence of pyrogallol (Figure 4).
Gallic acid also signiﬁcantly reduced pyrogallol-induced
toxicity, but at even lower concentrations (10–100nM;
Figure 5(c)). The eﬀect was less complete than for delphini-
din and aged delphinidin, but it is important to note that
the eﬀect of pyrogallol alone was more pronounced in this
particular set of experiments (~70% reduced viability com-
pared to 30–40%). 100 μM GA had a substantial additional
cytotoxic eﬀect, reducing cell viability to ~5% of control cells.
3.7. Eﬀects of Delphinidin and Gallic Acid on Hydrogen
Peroxide-Induced Cytotoxicity in HUVECs. Hydrogen
peroxide induced loss of cell viability by ~55% (Figure 6).
Only gallic acid (10 μM) signiﬁcantly protected against
H2O2-induced attenuation (~40% protected; Figure 6(c)).
There was a trend across all the phenolic treatments tested
at 10nM–10 μM concentrations to induce a protective eﬀect,
but the ﬁndings were not statistically signiﬁcant. In all
cases, coincubation with phenolic treatments at 100 μM
with H2O2 exacerbated H2O2-induced cell death (~80%
loss in viability; Figure 6).
3.8. Eﬀects of Delphinidin and Its Degradation Products on the
Viability of Pyocyanin-Induced Cytotoxicity in HUVECs. Pyo-
cyanin reduced cell viability by ~30% (Figure 7). Delphinidin,
aged delphinidin, and gallic acid oﬀered protection to
pyocyanin-treated cells, particularly at concentrations of
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Figure 5: Cell viability, measured by MTT, in HUVECs cotreated with pyrogallol (140 μM) and (a) delphinidin (Del), (b) aged delphinidin
(ag Del), or (c) gallic acid (GA). Values are shown as mean± SEM, (n = 7); ∗P < 0 05, ∗∗P < 0 01, and ∗∗∗P < 0 001, compared with the
pyrogallol-treated cells (one-way ANOVA with Dunnett’s posttest).
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10 μMand 1 μM; the other tested concentrations failed to sig-
niﬁcantly protect cells against pyocyanin (Figure 7). Contrary
to the data for H2O2 and pyrogallol-treated cells, there were
no additional cytotoxic eﬀects of 100 μM concentrations of
the phenolic treatments on pyocyanin-induced cell death.
3.9. Eﬀect of Delphinidin and Gallic Acid on Endogenous
Antioxidant Defences in Pyrogallol- (O2
∙−) Treated HUVECs
3.9.1. Eﬀect of Pyrogallol and Phenolics on Intracellular
Superoxide. Treatment of HUVECs with exogenous pyrogal-
lol induced an increase in intracellular superoxide, measured
using an intracellular ﬂuorescent probe (Figures 8(a) and
8(b); +86%); total ROS was not signiﬁcantly aﬀected (results
not shown). Cotreatment of cells with a moderate (1 μM)
concentration of either delphinidin (Figure 8(a)) or gallic acid
(Figure 8(b)) trended towards a reduction in intracellular
superoxide concentration, while cotreatment with 100 μM
delphinidin or gallic acid induced substantial increases in
intracellular superoxide (a further increase of +73% or
+41%, resp., beyond the pyrogallol-induced increase).
3.9.2. Intracellular Total GSH. Pyrogallol (180 μM) was
associated with a depression of total cellular GSH in
HUVECs by ~35%, after 24 h (P < 0 001, compared to
control; Figures 9(a) and 9(b)). Delphinidin (100 nM and
1 μM) signiﬁcantly protected against pyrogallol-associated
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Figure 6: Cell viability, measured by MTT, in HUVECs cotreated with hydrogen peroxide (130 μM) and (a) delphinidin- (Del-), (b) aged
delphinidin- (ag Del-), or (c) gallic acid- (GA-) treated HUVECs. Values are shown as mean± SEM (n = 6); ∗∗P < 0 01 and ∗∗∗P < 0 001
indicate the diﬀerence from oxidising agent treatment (one-way ANOVA with Dunnett’s posttest).
9Oxidative Medicine and Cellular Longevity
depression of total GSH in HUVECs at 24h (P < 0 001, for
both; Figure 9(a)), although the concentration of GSH did
not reach the same level as that of cells not treated with pyro-
gallol (control). Gallic acid at 100nM had an eﬀect similar in
magnitude to that of delphinidin, while gallic acid at 1 μM
concentration fully protected against oxidant-induced
depression of total glutathione (Figure 9(b)).
3.9.3. SOD Activity. Superoxide dismutase (SOD) activity in
HUVECs was low (<5mU/mg protein) in untreated cells.
Pyrogallol notably enhanced SOD activity (~10 times com-
pared to control; Figures 9(c) and 9(d)). Neither delphinidin
(Figure 9(c)) nor GA (Figure 9(d)) enhanced SOD activity
beyond that seen with pyrogallol alone; indeed, the trend
shown with both agents was to actively depress pyrogallol-
induced SODactivity in thismodel. The speciﬁcity of the assay
for SOD activity was conﬁrmed by testing equivalent HUVEC
extracts treated with pyrogallol with KCN immediately prior
to the assay. KCN inhibited SOD activity by ~87%, indicating
a strong speciﬁcity for SOD (n = 4; data not shown).
3.9.4. Catalase Activity. Pyrogallol treatment (180 μM) did
not signiﬁcantly change catalase activity in HUVECs at 24h
after treatment. Likewise, co-treatment with this oxidising
agent and either phenolic compound failed to have any sig-
niﬁcant impact on catalase activity in the cells (Figures 9(e)
and 9(f)).
4. Discussion
This study found that the anthocyanin, delphinidin, rapidly
degrades under physiological conditions and fails to oﬀer
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Figure 7: Cell viability, as measured by MTT assay, in HUVECs cotreated with pyocyanin (300 μM) and (a) delphinidin (Del), (b) aged
delphinidin (ag Del), and (c) gallic acid (GA). Values are shown as mean± SEM (n = 4); ∗P < 0 05 and ∗∗P < 0 01 compared with the
oxidising agent-treated cells (one-way ANOVA with Dunnett’s posttest).
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substantial antioxidant activity in vitro at concentrations rel-
evant to oral bioavailability. Nevertheless, it eﬀectively pro-
tects cultured endothelial cells against chemically induced
oxidative stress. The protective eﬀects of delphinidin were
hormesic in proﬁle, peaking at ~1 μM. The key degradation
product from delphinidin, gallic acid (GA), shared many of
the antioxidant protective characteristics of the parent com-
pound. Both delphinidin and gallic acid induced an increase
in total intracellular GSH but did not increase activity of
either SOD or catalase. The inference of these ﬁndings is that
the antioxidant protective eﬀects of delphinidin might not be
mediated by direct antioxidant activity and do not necessarily
require the presence of the parent compound. They are, how-
ever, associated with increased intracellular GSH that is as
likely to be triggered by GA as by delphinidin itself. This
association does not unequivocally identify GSH as the cause
of the eﬀect, but it is one explanation.
4.1. Stability of Delphinidin.Delphinidin is more stable under
physiological conditions when present as a glycoside [75].
However, its stability declines rapidly when deprived of the
sugar moiety during transit through the gut. Our results indi-
cate that delphinidin aglycone is not stable under physiolog-
ical conditions, with a short half-life of ~30min. Ascorbic
acid oﬀers some protection against decomposition, but the
half-life is still <2h in the presence of this antioxidant.
LC-MS/MS data indicated that delphinidin degraded
spontaneously to gallic acid and phloroglucinol aldehyde
under physiologically relevant conditions in tissue culture
medium. The fact that both degradation products appeared
in the solution after only 30 minutes indicates the rapidity
of the process and conﬁrms previous observations [39, 41].
The presence of the intermediate degradation product, chal-
cone, is an indicative that the chemical process involved is
similar to that previously described [39, 41, 56]. From a
bioavailability perspective, these data imply that delphini-
din, stripped of its sugar in the gut, is unlikely to persist
for long in the blood or in tissue. It is likely that the more
stable products of delphinidin decomposition and metabo-
lism, including gallic acid, are more likely to have the
opportunity to mediate any protective eﬀects that are typ-
ically attributed to delphinidin.
4.2. In Vitro Anti- and Prooxidant Eﬀects of Delphinidin and
Gallic Acid. FRAP analysis is only detected reducing activity
for delphinidin and gallic acid at concentrations of ≥10 μM;
although the eﬀect was signiﬁcantly greater for delphinidin
than gallic acid, the absolute diﬀerence was only ~5%. In
interpreting these data, it is important to highlight that
FRAP, along with many of the other in vitro “antioxidant”
assays, actually measures reducing power, rather than free
radical scavenging. In addition, this technique will not iden-
tify any prooxidant eﬀects. EPR spectrometry exclusively
detects free radicals [59] and, through use of a selective spin
trap for oxygen-centred radical generation, can provide a
direct measurement of radical-mediated oxidising potential.
The EPR data generated showed that both delphinidin and
gallic acid exhibit prooxidant activities at ≥10 μM, with some
modest scavenging eﬀects of oxygen-centred radical species
generated spontaneously in tissue culture medium at lower
concentrations. The prooxidant ﬁnding is not without prece-
dent: phenolic compounds, including gallic acid, have been
previously shown to have prooxidant properties [43, 44],
possibly via reduction of transition metal ions and conse-
quent induction of Fenton chemistry [59]. Several research
groups [44, 75, 76] have reported that phenolic compounds,
and gallic acid in particular, can oxidise readily in tissue
culturemedium and produce free radicals, such as superoxide
radical (O2
∙−), H2O2, and quinones. Indeed, autoxidation
of phenolic compounds, and consequential free radical
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Figure 8: Eﬀect of pyrogallol alone and (a) pyrogallol + delphinidin (Del) or (b) pyrogallol + gallic acid (GA) on intracellular superoxide in
HUVECs. Values are shown as mean± SEM (n = 6–8). ∗P < 0 05 and ∗∗∗P < 0 001 compared to pyrogallol alone (one-way ANOVA with
Dunnett’s posttest).
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Figure 9: Total GSH concentration (a, b), SOD activity (c, d), and catalase activity (e, f) in HUVECs treated with delphinidin (Del; a, c, and e)
and gallic acid (GA; b, d, and f) at concentrations of 1 μM and 100 nM, measured at 24 h. Values are shown as mean± SEM (n = 6); ∗P < 0 05,
∗∗P < 0 01, and ∗∗∗P < 0 001 indicate the diﬀerence from oxidising agent treatment (one-way ANOVA with Dunnett’s posttest).
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generation, could explain their cytotoxicity towards cancer
cells at high concentrations [44]. What is clear from the
FRAP and EPR data is the complexity that exists when deal-
ing with phenolic compounds in relation to their reducing
capacity, pro- and antioxidant activity. Certainly, the concept
that concentration-dependent reducing power (FRAP)
translates into antioxidant capacity in vivo does not hold on
account of a concurrent, counterintuitive increase in
oxygen-centred free radical generation; if anything, the EPR
data indicated that only gallic acid at a concentration of
~1 μM shows signs of a modest direct antioxidant eﬀect.
4.3. Cytotoxicity and Protective Eﬀects of Delphinidin and
Gallic Acid in HUVECs. Physiologically relevant concentra-
tions (≤10 μM) of delphinidin and gallic acid did not induce
cell death in HUVECs in the absence of experimental oxida-
tive stress. However, at supraphysiological concentrations
(100 μM), capable of powerful reducing eﬀects and concom-
itant oxygen-centred free radical production, there was a sub-
stantial cytotoxic eﬀect measured by a loss of cell membrane
integrity (primary or secondary necrosis). That the threshold
for cytotoxicity coincides with detectable reducing power and
free radical generation might suggest that cytotoxicity is
driven by the oxidant-free radical production, in turn medi-
ated by reduced metal ion-mediated Fenton chemistry.
Whatever the mechanism, however, it is clear that these
phenolic agents become toxic at concentrations above
~10 μM, which could explain why they are largely excluded
in the gut and why plasma concentrations are maintained
below ~10 μM.
4.4. Phenolic Compounds Protect against Oxidative Stress-
Induced Cell Death: A Hormesic Relationship. Delphinidin,
aged delphinidin, and GA had a substantial protective eﬀect
against chemically induced oxidative stress in HUVECs.
The degree of protection was speciﬁc to the oxidant used; it
was most pronounced in HUVECs exposed to superoxide
radical generated from pyrogallol and via oxidative stress
on account of pyocyanin-induced cell death. Protection was
concentration dependent: for pyrogallol-treated cells,
100 nM and 1 μM concentrations had the most pronounced
beneﬁcial eﬀects, but very low concentrations (10 nM) also
oﬀered signiﬁcant protection. In the case of both delphinidin
and aged delphinidin, protection was suﬃcient to fully
restore oxidant-induced loss of cell viability. The eﬀective-
ness of GA was signiﬁcantly weaker compared to that of
delphinidin and aged delphinidin, but this might be due to
the fact that the extent of cell death induced by pyrogallol
alone in the GA experiment was considerably higher than
that in the delphinidin and aged-delphinidin experiments.
In pyocyanin-treated cells, optimal eﬀects were seen at 1–
10 μM, and for H2O2, only 10 μMGA showed partial protec-
tive eﬀect. While the pattern of eﬀects was similar for all of
the test agents, there were subtle diﬀerences in the optimal
concentrations required for each and the relative eﬀective-
ness against the diﬀerent oxidant stressors. In general, the
optimal concentration for GA was ~10-fold lower than that
for delphinidin and aged delphinidin, suggesting that treat-
ment throughout 24 h with this metabolic product is more
eﬃcacious than initial treatment with delphinidin, despite
the likely degradation of the latter to ultimately generate gal-
lic acid. The data strongly suggest that delphinidin or indeed
the unstable intermediate chalcones are not a requirement
for antioxidant protection in this model.
Data involving direct measurement of intracellular
superoxide using an intracellular ﬂuorescent probe sup-
ported the concept that both delphinidin and GA at
100 μM actively induce intracellular oxidative stress, suggest-
ing that the cytotoxic eﬀects seen in the cells are associated
with oxidative stress. Meanwhile, the trend for low (1 nM)
and intermediate concentrations was to quench intracellular
superoxide, in keeping with the hormesic relationships seen
through measurement of cell death in this model.
The concentration range chosen for this study embraces
those relevant to in vivo bioavailability (100 nM–~1 μM)
[12, 14, 33, 37]. However, in order to obtain a better insight
into the eﬀectiveness of phenolic compounds, higher concen-
trations were included in the experimental design. Though
the protective eﬀects of the test agents were concentration
dependent, the relationship did not follow the traditional
sigmoidal log-concentration response relationship in which
increasing eﬀect (antioxidant protection in this case)
increases with concentration and then reaches plateau.
Instead, it was found that, whereas low to intermediate
concentrations showed protective eﬀects, the beneﬁt was
not seen with 100 μMdelphinidin, aged delphinidin, or gallic
acid. Indeed, in the cells treated with pyrogallol or H2O2, the
cytotoxic eﬀect of these agents is clearly additive to that
caused by the chemical oxidant. The phenomenon where
the same agent can be harmful in higher concentrations
and beneﬁcial at lower concentrations is called hormesis
[77] and has previously been described for resveratrol, where
a protective eﬀect at low doses but an adverse eﬀect at higher
doses is observed [78]. Delphinidin and its degradation prod-
ucts display classic hormesis in HUVECs in the presence of
an oxidant (particularly superoxide induced by pyrogallol
or from pyocyanin-induced oxidative stress and cell death).
Optimal beneﬁt coincided with the concentrations that are
likely to be available from dietary ingestion.
The results not only suggest that the positive attributes of
polyphenolic compounds are overrated but also act as a
reminder that natural does not automatically mean safe
and more does not necessarily mean better [11]. It should
be emphasised, however, that the log relationship of concen-
tration with eﬀect, coupled with the highly eﬀective screening
of phenolic compounds in the gut, ensures that levels of
exposure that might generate a toxic eﬀect are unachievable
through diet. It would become an important consideration,
however, that polyphenolic compounds should be consid-
ered for intravenous delivery or incorporation into implant-
able devices.
4.5. Impact of Delphinidin and Gallic Acid on Intracellular
Defences—Secondary Antioxidant Eﬀects. Total intracellular
GSH concentrations increased in pyrogallol-treated
HUVECs in response to both delphinidin and gallic acid
present at 100 nM–1 μM; the eﬀect of gallic acid was
suﬃciently powerful to totally prevent pyrogallol-induced
13Oxidative Medicine and Cellular Longevity
depression of total GSH. It is important to recognise that the
observed association between protection by GA and protec-
tion of GSH cannot in itself establish that an increase in
intracellular GSH is responsible for the protective eﬀects of
gallic acid—it could equally infer that gallic acid or delphini-
din oﬀers direct antioxidant protection resulting in protec-
tion of GSH. However, we consider the latter explanation to
be unlikely on account of the lack of antioxidant activity of
gallic acid at the relevant concentration (1 μM) in any of
the antioxidant assays used. In addition, the eﬀect seen was
on total GSH concentration not the balance of reduced/
oxidised GSH composition, inferring modulation of GSH
synthesis/breakdown rather than antioxidant protection.
Should phenolic induction of GSH be conﬁrmed, the concept
is intriguing because it could drive a substantial ampliﬁcation
of antioxidant capacity: the impact of 1 μM gallic acid on
total cellular antioxidant capacity would be negligible, but
through this process, the increase in intracellular GSH could
be in the millimolar range.
This result contradicts those of previous studies in which
both delphinidin [78] and gallic acid [79, 80] contributed sig-
niﬁcantly to GSH depletion and an increase in ROS produc-
tion. However, the concentrations used in the previous
studies were substantially higher (25–100 μM and 10–
400 μM for delphinidin and gallic acid, resp.)—levels at
which our data suggest that both delphinidin and gallic acid
are capable of generating oxygen-centred free radicals. These
discrepancies highlight the importance of close attention to
the concentration of antioxidants applied in cell culture and
their relevance to in vivo bioavailability.
Similar changes were not found for the key antioxidant
defence enzymes that we investigated (SOD and catalase),
suggesting a fairly targeted impact of these treatments. This
conclusion is in line with a recent study [81], in which gallic
acid was found to cause an increase in GST-alpha 3 without
having a signiﬁcant impact on SOD activity. Likewise, gallic
acid increased activity of rat liver microsomal glutathione
S-transferase MGST-1, but only in the absence of catalase
and SOD [82].
The underlying mechanism by which delphinidin and
gallic acid increase intracellular total GSH is not yet known,
but upregulation of the rate-limiting enzyme responsible
for GSH synthesis, glutamyl cysteine ligase (GCL), is a
credible option. Polyphenols are known to activate the
heterodimers of NF-E2-related factors 2 (Nrf2)/antioxi-
dant-responsive element (ARE) pathway, leading to induc-
tion of detoxifying enzymes [49, 83], including GCL
amongst others [84], and we postulate that gallic acid might
activate a similar pathway.
4.6. Mechanism and Implications. There is a growing body of
evidence that phenolic compounds are treated as xenobiotics
by cells [34, 85]. Therefore, the extensive metabolism that
they are exposed to, coupled with their low bioavailability,
may be a result of the natural defence against a potentially
toxic insult. This concept would explain the relatively low
concentrations of (poly)phenolics found in plasma
(100 nM–10 μM), which is not dramatically aﬀected by
ingestion of phenolic-rich food [2, 14, 54]. The small amount
of parent polyphenols that overcome the defence mecha-
nism, together with the simple phenolic compounds that rep-
resent degradation products, imposes a mild noxious eﬀect,
driving Nrf-2/ARE-1-mediated upregulation of intracellular
defence enzymes and xenobiotic-metabolising enzymes,
leading to the observed antioxidant and cytoprotective eﬀect.
The results of this study provide support for the view that
delphindin—and potentially other berry-derived polyphe-
nols—has the capability to protect endothelial cells against
oxidative stress, perhaps via an indirect route. In contradic-
tion to common opinion, the protection oﬀered does not
appear to be related to direct antioxidant properties of the
polyphenol itself; instead, modulation of intracellular defence
mechanisms is a possible alternative mode of action. More-
over, this study suggests that degradation products are likely
to be responsible for the observed biological activities, rather
than the parent compound itself. This has profound implica-
tions for in vivo bioavailability studies, suggesting that our
attention might have been previously misplaced and that
we should instead measure phenolic metabolites, which can
also confer bioactivity and might be present at concentra-
tions higher than the parent compound(s).
Dietary polyphenols have health-promoting qualities, but
their mode of action still remains equivocal. A full under-
standing of the bioactive agents in vivo and their mode of
action will help to shape public health advice. There are also
profound consequences of our ﬁndings for research practice,
particularly with respect to the relevance of in vitro antioxi-
dant (reducing capacity) testing as an indication of putative
health beneﬁts of food extracts or polyphenolic compounds.
5. Conclusions
This research adds to the growing literature that explains the
apparent disparity between the very low bioavailability and
rapid metabolism of complex polyphenols and their ability,
nevertheless, to evoke a powerful antioxidant eﬀect. At high
concentrations, delphinidin and its major metabolite, GA,
have the potential to be toxic, but at subtoxic concentrations,
they can protect against oxidative stress through a mecha-
nism that is associated with increased glutathione. The impli-
cations are that antioxidant activity of polyphenols might not
have any bearing on their ability to protect cells against oxi-
dative stress; instead, it is the capability of the bioavailable
metabolites to stimulate antioxidant defence pathways that
likely drives the protective eﬀect, in a manner unrelated to
the in vitro reducing capacity of the parent molecule [55].
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